Navigation Links
Bradmer announces 2008 fourth quarter and fiscal year operational and financial results

res have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state regulatory agency in the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject to the requirements of Rule 904 of Regulation S of the Securities Act or such other applicable exemption thereunder, and other applicable state securities laws.

Except for historical information, this press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Company's ongoing quarterly and annual reporting.

    Financial results are included below:

    Bradmer Pharmaceuticals Inc.
    Balance Sheets
    US $
                                                   December 31,  December 31,
                                                          2008          2007
                                                   ------------  ------------

      Cash and cash equivalents                    $ 8,245,455   $19,469,337
      Amounts receivable                                12,520       143,722
      Prepaid expenses and other assets                 27,158        24,029
                                                   ------------  ------------

                                                     8,285,133    19,637,088

    Patent rights                                      711,054       685,165
                                                   ------------  --
SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Bradmer implements cash conservation plan
2. Bradmer provides clinical trial update and announces evaluation of strategic alternatives
3. Bradmer to participate in panel presentation at RBC Capital Markets Healthcare Conference
4. Bradmer to present poster on progression free survival and overall survival data from Neuradiab(TM) Phase II trials at Society for Neuro-Oncology Meeting
5. Bradmer announces 2008 third quarter operational and financial results
6. Bradmer to present at Rodman & Renshaw Healthcare Conference
7. Bradmer receives FDA approval to proceed with Phase III clinical trial
8. Bradmer announces 2008 first quarter operational and financial results
9. Bradmer announces new additions to management team
10. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
11. Notice of Bradmer Pharmaceuticals Conference Call
Post Your Comments:
(Date:10/9/2015)... ... October 09, 2015 , ... ViewPoint Center, a teen mental ... teenagers facing mental illness, the stigma associated with mental illness causes many to hide ... understands the importance of supporting teens with mental illness , providing teens with ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... placement counseling, recently opened its newest office in Maryland – its Bethesda ... with a background as a project management technology consultant to many of the ...
(Date:10/9/2015)... ... ... race options will be available for the Run 4 Recovery sponsored by WestBridge ... 4810 North Himes Avenue, in Tampa. The family friendly event will start with opening remarks ... a one-mile walk, followed by an award ceremony at 10 a.m. As part of a ...
(Date:10/9/2015)... ... October 09, 2015 , ... Safe Space, a non-profit organization ... launched a new website to mark Domestic Violence Awareness Month. , This ... immediately, whether through an emergency hotline, support group, or shelter. The revamped site ...
(Date:10/9/2015)... ... October 09, 2015 , ... Bag Tags Inc. will provide ... the media at the annual IRONMAN World Championship in Kailua-Kona, Hawaii, this ... which has taken place in Hawaii every year since 1978. , As part ...
Breaking Medicine News(10 mins):
... Dec. 18 Cyberonics, Inc. (Nasdaq:,CYBX) announced that ... an agreement with Ethicon Endo-Surgery granting exclusive rights ... vagus nerve,stimulation (VNS) for the treatment of obesity ... patients., Ethicon Endo-Surgery has agreed to pay ...
... HILL, N.C., Dec. 18 Despite all the ... a long and,expensive trip from the lab to ... money pay off, best-in-class pharmaceutical companies have learned,to ... process,according to research from Best Practices, LLC., ...
... team of scientists that includes a Saint Louis University ... of brain diseases that include multiple sclerosis, Alzheimers disease, ... Lancet Neurology. , Their review article, which focuses on ... available in an early online edition of the prestigious ...
... stick to the same guidelines about alcohol consumption as ... to the over 65s, and may even bring health ... School in the South West of England. , Researchers ... in England and the US and looked at the ...
... Hemodynamic and Implantability Characteristics, MINNEAPOLIS, Dec. ... ), manufacturer and marketer of state-of-the-art cardiac,surgery ... and Drug,Administration (FDA) approval for the ATS ... ), The ATS AP360 ...
... will be running the,story December 17th and 18th on ... TO A NEW ROBOT THAT MEASURES AND MIXES THEIR,TREATMENT., ... and,a patient were interviewed by CBS News. The story ... syringes and IV bags.,University of Colorado Hospital and Baylor ...
Cached Medicine News:
(Date:10/9/2015)... 2015 Adheron Therapeutics, a privately held ... , United States , ... acquired by Roche.  Adheron Therapeutics has developed a ... a cell surface protein called Cadherin-11 in order ... inflammatory and autoimmune diseases such as rheumatoid arthritis ...
(Date:10/8/2015)... , October 9, 2015 ... or diagnostic colonoscopy. The NOCT study also assessed ... NER1006. --> ® ) in adult ... NOCT study also assessed the compliance, safety, patient ... Norgine today announced positive top line results for ...
(Date:10/8/2015)... 8, 2015  Trovagene, Inc., (NASDAQ:   TROV) ... the presentation of results from a field experience ... Monitoring SM (PCM) platform to accurately identify ... to determine appropriate therapy for patients. Mark ... is delivering the results today in an oral ...
Breaking Medicine Technology:
... Va., Aug. 8, 2011 Science Applications International ... has completed the acquisition of Vitalize Consulting Solutions ... and information technology (IT) services for healthcare enterprises. ... the commercial hospital market that are implementing electronic ...
... HOPKINTON, Mass., Aug. 8, 2011 Caliper Life Sciences, ... it has favorably settled two lawsuits with Carestream Health, ... February 2010, Caliper, its wholly owned subsidiary, Xenogen, and ... its instrument systems induced infringement of seven imaging patents ...
Cached Medicine Technology:
... assay is a sensitive, simple ... permits the detection of all ... and can distinguish between ... P. vivax . In addition, ...
Malaria Pf/Pv Assay Range...
ADVANTAGE MALARIA STIX is a visual, rapid and sensitive immunoassay for the qualitative differential detection of P.falciparum (P.f) and P.vivax (P.v) malaria in Human Blood only....
Malaria device / strip (2 line, P.f.-HRP2 Test)...
Medicine Products: